Innovators Test Older Approaches For Development Of New Malaria Vaccine

Bill & Melinda Gates Foundation’s “Impatient Optimists”: Innovation: Everything Old is New Again
Trevor Mundel, president of global health at the Bill & Melinda Gates Foundation, discusses the work of Miguel Prudencio and his colleagues at Lisbon’s Instituto de Medicina Molecular, who are attempting to use an older approach to vaccine development and apply it to malaria. The researchers aim to expose people to a version of malaria that causes disease in animals but does not cause serious symptoms in humans, thereby theoretically allowing humans to develop immunity to the more dangerous human variety (2/7).